Carboplatin (every 21 days) and divided-dose paclitaxel (days 1, 11): rationale and tolerance in chemotherapy naïve women with high-grade epithelial cancers of Mullerian origin.
| Image |  |
|---|---|
| Description | scientific article published on 7 March 2018 |
| Author/s |
author: Franco Muggia David Kudlowitz |
| Publication date | March 7, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |